BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 31

• Press Releases

  enGene Announces Updated Interim Results From LEGEND Pivotal Cohort

  May 7, 2026

   · 

  12 min read
• Press Releases

  Delcath Systems Announces Presentation of New Data on Percutaneous Hepatic Perfusion with Melphalan in Liver-Dominant Metastatic Breast Cancer at ESMO Breast Cancer 2026

  May 7, 2026

   · 

  4 min read
• Press Releases

  Parabilis Medicines Appoints Biopharmaceutical Finance Leader Alan M. Sebulsky to Board of Directors

  May 7, 2026

   · 

  2 min read
• Press Releases

  Charles River Laboratories Announces First-Quarter 2026 Results

  May 7, 2026

   · 

  20 min read
• Press Releases

  GI Partners Completes Acquisition of the CDMO and Cell Solutions Businesses from Charles River Laboratories and forms Rose BioSolutions

  May 7, 2026

   · 

  4 min read
• Press Releases

  Bright Uro Receives FDA Clearance For Glean® Abdominal Sensor

  May 7, 2026

   · 

  4 min read
• Press Releases

  Mezzion Reports Pre-IND FDA Feedback on the Development of Udenafil in ADPKD

  May 7, 2026

   · 

  2 min read
• Press Releases

  ImmunityBio Reports Record Q1 2026 Results: Net Product Revenue Increased Nearly 2.7x Year-Over-Year to $44 Million in Q1 2026 Expanding on the 2025 Full Year 700% Year-Over-Year Revenue Growth; Cash and Marketable Securities Total $381 Million

  May 7, 2026

   · 

  14 min read
• Press Releases

  Harmony Biosciences Reports Q1 Financial Results and Confirms 2026 Net Revenue Guidance of Over $1 Billion; Reinforces 2026 Strategic Priorities

  May 7, 2026

   · 

  15 min read
• Press Releases

  Ironwood Pharmaceuticals Reports Strong First Quarter 2026 Results With 97% Year-Over-Year LINZESS U.S. Net Sales Growth; Maintains Full-Year 2026 Financial Guidance

  May 7, 2026

   · 

  19 min read